Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: A prospective surveillance study.

Published on May 25, 2021in Journal of Infection6.072
· DOI :10.1016/J.JINF.2021.05.019
Yaoju Tan2
Estimated H-index: 2
,
Yunfeng Deng5
Estimated H-index: 5
(SDU: Shandong University)
+ 36 AuthorsYu Pang23
Estimated H-index: 23
(Capital Medical University)
Sources
Abstract
BACKGROUND We aimed to address the knowledge gap that exists regarding the epidemiological, demographic, and clinical characteristics of nontuberculous mycobacterial pulmonary diseases (NTM-PDs) among smear-positive patients with symptoms suggestive of pulmonary tuberculosis (PTB) in China. METHODS Prospective and national surveillance of NTM-PD was performed from 17 hospitals within the China Nontuberculous Mycobacteria Surveillance Study (CNTMS). Patients were eligible for inclusion if they had positive smears during hospitalization. Sputum specimens were collected for molecular species identification. RESULTS 6,766 patients with valid results were included, consisting of 6,236 (92.2%) with PTB, 458 (6.8%) with NTM-PD, and 72 (1.0%) with colonisation. The proportion of NTM-PD in PTB patients exhibited significant geographic diversity, ranging from 3.2% in the northwest to 9.2% in the south. The most prevalent species was Mycobacterium intracellulare, followed by Mycobacterium abscessus complex. Females, elderly people, and patients with bronchiectasis or COPD are at high risk for developing NTM-PD, while patients with diabetes have a lower risk of NTM-PD when compared with non-diabetic patients. Regarding clinical symptoms, lower rates of persistent cough and weight loss were noted in NTM-PD patients than in PTB patients. CONCLUSIONS Approximately one-fifteenth of PTB patients are afflicted with nontuberculous mycobacterial infections in China. The prevalence of NTM shows geographic diversity across the country, and it showed a gradual increase from north to south and from west to east. NTM-PD patients are prone to exhibit less severe clinical symptoms than PTB patients, highlighting the importance of raising awareness of NTM diseases to improve decision making on how to best screen, diagnose, and treat NTM in TB-endemic settings.
References34
Newest
#1Charles L. Daley (University of Colorado Denver)H-Index: 71
#2Jonathan M. Iaccarino (BU: Boston University)H-Index: 11
Last. Kevin L. Winthrop (OHSU: Oregon Health & Science University)H-Index: 72
view all 21 authors...
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites. This guideline focuses on pulmonary disease in adults (without cystic fibrosis or human immunodeficiency virus infection) caused by the most common NTM pathogens such as Mycobacterium avium complex, Mycobacterium kansasii, and Mycobacterium xenopi among the slowly growing NTM and Mycobacterium abscessus among ...
Source
#1Charles L. Daley (University of Colorado Denver)H-Index: 71
#2Jonathan M. Iaccarino (BU: Boston University)H-Index: 11
Last. Kevin L. Winthrop (OHSU: Oregon Health & Science University)H-Index: 22
view all 21 authors...
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites. This guideline focuses on pulmonary disease in adults (without cystic fibrosis or human immunodeficiency virus infection) caused by the most common NTM pathogens such as Mycobacterium avium complex, Mycobacterium kansasii, and Mycobacterium xenopi among the slowly growing NTM and Mycobacterium abscessus among ...
Source
#1Kai Ling Chin (UMS: Universiti Malaysia Sabah)H-Index: 5
#2Maria E. Sarmiento (RMIT: RMIT University)H-Index: 13
Last. Armando Acosta (RMIT: RMIT University)H-Index: 16
view all 5 authors...
Currently, there is a trend of increasing incidence in pulmonary non-tuberculous mycobacterial infections (PNTM) together with a decrease in tuberculosis (TB) incidence, particularly in developed countries. The prevalence of PNTM in underdeveloped and developing countries remains unclear as there is still a lack of detection methods that could clearly diagnose PNTM applicable in these low-resource settings. Since non-tuberculous mycobacteria (NTM) are environmental pathogens, the vicinity favour...
Source
#1Yoshifumi Uwamino (Keio: Keio University)H-Index: 10
#2Tomoyasu Nishimura (Keio: Keio University)H-Index: 16
Last. Naoki Hasegawa (Keio: Keio University)H-Index: 33
view all 12 authors...
Background The risk factors for Mycobacterium avium complex lung disease (MAC-LD) are not well known. We hypothesized that low serum estradiol (E2) levels are related to MAC-LD as most patients with MAC-LD are postmenopausal women.
Source
#1Ye Xu (Ha Tai: Xiamen University)H-Index: 64
#2Bin Liang (Ha Tai: Xiamen University)H-Index: 2
Last. Qingge Li (Ha Tai: Xiamen University)H-Index: 24
view all 14 authors...
ABSTRACT The sustained increase in the incidence of nontuberculous mycobacterial (NTM) infection and the difficulty in distinguishing these infections from tuberculosis constitute an urgent need for NTM species-level identification. The MeltPro Myco assay is the first diagnostic system that identifies 19 clinically relevant mycobacteria in a single reaction based on multicolor melting curve analysis run on a real-time PCR platform. The assay was comprehensively evaluated regarding its analytical...
Source
#1Jennifer R. HondaH-Index: 17
#2Ravleen VirdiH-Index: 3
Last. Edward D. Chan (University of Colorado Denver)H-Index: 63
view all 3 authors...
Seminal microbiological work of environmental NTM includes the discovery that NTM inhabit water distribution systems and soil, and that the species of NTM found are geographically diverse. It is likely that patients acquire their infections from repeated exposures to their environments, based on the well-accepted paradigm that water and soil bioaerosols – enriched for NTM – can be inhaled into the lungs. Support comes from reports demonstrating NTM isolated from the lungs of patients are genetic...
Source
#1Petra ZimmermannH-Index: 20
#2Adam FinnH-Index: 59
Last. Nigel Curtis (UOU: University of Ulsan)H-Index: 65
view all 3 authors...
Background: The incidence of nontuberculous mycobacterial (NTM) infections is increasing worldwide, particularly NTM lymphadenitis and skin infections (Buruli ulcer). This review summarizes the evidence for the protective effectiveness of BCG vaccination against NTM disease. Methods: A systematic search using PRISMA guidelines was done for controlled studies investigating the protective effectiveness of BCG vaccination against NTM disease in immunocompetent individuals. This revealed 10 studies,...
Source
#1D. Rebecca Prevots (NIH: National Institutes of Health)H-Index: 34
#2Robert LoddenkemperH-Index: 24
view all 4 authors...
The cost of nontuberculous mycobacterial pulmonary disease is substantial, with high hospitalisation and drug costs http://ow.ly/8xcl309VgDG
Source
#1Yu Pang (CCDC: Chinese Center for Disease Control and Prevention)H-Index: 23
Nontuberculous mycobacteria (NTM) are a heterogeneous group of widely distributed environmental bacteria [1]. Despite generally low pathogenicity in humans, NTM can cause various illnesses especially in HIV-infected patients or those with immunodeficiencies [2]. In recent years, NTM-related disease incidence has increased significantly [3] and, despite China's tuberculosis (TB) programme having more than halved TB prevalence over the past 20 years [4], population-based data indicate that the pro...
Source
#2Dirk WagnerH-Index: 40
Last. Jessica RademacherH-Index: 14
view all 8 authors...
We analyzed routine statutory health insurance claim data to determine prevalence of nontuberculous mycobacterial pulmonary disease in Germany. Documented prevalence rates of this nonnotifiable disease increased from 2.3 to 3.3 cases/100,000 population from 2009 to 2014. Prevalence showed a strong association with advanced age and chronic obstructive pulmonary disease.
Source
Cited By1
Newest
Although the prevalence and incidence of bronchiectasis are rising worldwide, basic epidemiologic data have not been reported in Korea. Therefore, this study was conducted to investigate epidemiological characteristics of bronchiectasis and NTM (nontuberculous mycobacteria) pulmonary diseases in Korea using the National Health Insurance Service-National Sample Cohort (NHIS-NSC) data. The relative risks of prevalence and incidence after adjusting for demographic characteristics were evaluated by ...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.